HAZLET, N.J. - TelAve -- In this symposium, a multidisciplinary expert faculty will describe best practices for prevention and treatment of hyperkalemia, enabling HF patients to continue and optimize guideline-directed medical therapies (GDMTs). A "real-world" case will emphasize to HF clinicians key messages and recommendations for clinical practice.

Click here for more information

CHAIR

Muthiah Vaduganathan, MD, MPH
Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts

FACULTY

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Officer--Research and Innovation
Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Akshay Desai, MD, MPH
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Robert Page, PharmD, MSPH, BCPS, BCGP

More on TelAve News

• America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
• Data Tiles Introduces the Decision-Driven Enterprise to North America
• Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
• eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
• Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability

Professor, Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado

Educational Objectives

• Recognize heart failure patients at risk for developing hyperkalemia
• Describe the relationship between hyperkalemia, suboptimal RAASi therapy and poor clinical outcomes
• Explain the data with, and demonstrate prudent use of novel potassium binders

Target Audience
This program is intended for clinicians who manage patients with heart failure.

Educational Grant
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants
accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.